Nycomed to buy branded generics from Zentiva
This article was originally published in Scrip
Executive Summary
Nycomed is to buy 20 branded generics from Zentiva, now part of Sanofi-Aventis, to strengthen its position in Central and Eastern Europe, particularly the Czech Republic and Slovakia. The products have an annual turnover of around €17 million.